Dr Julie-Anne White (Director)

Dr White completed her MSc and PhD in pharmacology at the Institute of Psychiatry, University of London and has more than 15 years experience working in Europe in start-up biotechnology and pharmaceutical companies including Wyeth, Merck, Sharpe and Dohme and Cerebrus (now Vernalis plc).

Since returning to Australia in 1998, Dr White has held Senior Executive,  MD/CEO and Board positions in public and private biotechnology companies and Cooperative Research Centres.

Julie has extensive experience in managing start-up companies, commercialisation, negotiating and managing large complex multiparty ventures, establishing robust governance systems underpinning collaborative research programs.

Dr. White maintains a significant senior international executive network in the pharmaceutical and biotechnology industry expanding Asia, Europe and North America.